Characterization of novel airway submucosal gland cell models for cystic fibrosis studies

被引:17
作者
da Paula, AC
Ramalho, AS
Farinha, CM
Cheung, J
Maurisse, R
Gruenert, DC
Ousingsawat, J
Kunzelmann, K
Amaral, MD
机构
[1] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA
[2] Natl Inst Hlth Dr Ricardo Jorge, Ctr Human Genet, Lisbon, Portugal
[3] Univ Lisbon, Fac Sci, Dept Chem & Biochem, P-1699 Lisbon, Portugal
[4] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
[5] Univ Vermont, Dept Med, Burlington, VT USA
[6] Univ Regensburg, Dept Physiol, D-8400 Regensburg, Germany
关键词
CFTR; cystic fibrosis; CF cellular model; epithelial cells; Calu-3; submucosal gland; airway cell line;
D O I
10.1159/000087235
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cultured airway,epithelial cells are widely used in cystic fibrosis (CF) research as in vitro models that mimic the in vivo manifestations of the disease and help to define a specific cellular phenotype. Recently, a number of in vitro studies have used an airway adenocarcinoma cell line, Calu-3 that expresses submucosal gland cell features and significant levels of the wild-type CFTR mRNA and protein. We further characterized previously described CF tracheobronchial gland cell lines, CFSMEo- and 6CFSMEo- and determined that these cell lines are compound heterozygotes for the F508del and Q2X mutations, produce vestigial amounts of CFTR mRNA, and do not express detectable CFTR protein. Electrophysiologically, both cell lines are characteristically CF in that they lack cAMP-induced Cl- currents. In this study the cell lines are evaluated in the context of their role as the CF correlate to the Calu-3 cells. Together these cell systems provide defined culture systems to study the biology and pathology of CF. These airway epithelial cell lines may also be a useful negative protein control for numerous studies involving gene therapy by cDNA complementation or gene targeting. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:251 / 262
页数:12
相关论文
共 74 条
[41]  
Kunzelmann K, 1999, Rev Physiol Biochem Pharmacol, V137, P1
[42]   AN IMMORTALIZED CYSTIC-FIBROSIS TRACHEAL EPITHELIAL-CELL LINE HOMOZYGOUS FOR THE DELTA-F508 CFTR MUTATION [J].
KUNZELMANN, K ;
SCHWIEBERT, EM ;
ZEITLIN, PL ;
KUO, WL ;
STANTON, BA ;
GRUENERT, DC .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1993, 8 (05) :522-529
[43]  
KUNZELMANN K, 1995, IN VITRO CELL DEV-AN, V31, P617
[44]  
Lechner JF., 1985, Methods of Cell Science, V9, P43, DOI [10.1007/BF01797773, DOI 10.1007/BF01797773]
[45]   LOCALIZATION OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR IN PANCREAS [J].
MARINO, CR ;
MATOVCIK, LM ;
GORELICK, FS ;
COHN, JA .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (02) :712-716
[46]   Sensitivity of a renal K+ channel (ROMK2) to the inhibitory sulfonylurea compound glibenclamide is enhanced by coexpression with the ATP-binding cassette transporter cystic fibrosis transmembrane regulator [J].
McNicholas, CM ;
Guggino, WB ;
Schwiebert, EM ;
Hebert, SC ;
Giebisch, G ;
Egan, ME .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :8083-8088
[47]  
Mendes Filipa, 2004, J Cyst Fibros, V3 Suppl 2, P69, DOI 10.1016/j.jcf.2004.05.016
[48]   DIFFERENTIAL LOCALIZATION OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR IN NORMAL AND CYSTIC-FIBROSIS AIRWAY EPITHELIUM [J].
PUCHELLE, E ;
GAILLARD, D ;
PLOTON, D ;
HINNRASKY, J ;
FUCHEY, C ;
BOUTTERIN, MC ;
JACQUOT, J ;
DREYER, D ;
PAVIRANI, A ;
DALEMANS, W .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1992, 7 (05) :485-491
[49]  
Ramalho Anabela S, 2004, J Cyst Fibros, V3 Suppl 2, P11, DOI 10.1016/j.jcf.2004.05.004
[50]   Transcript analysis of the cystic fibrosis splicing mutation 1525-1G>A shows use of multiple alternative splicing sites and suggests a putative role of exonic splicing enhancers -: art. no. e88 [J].
Ramalho, AS ;
Beck, S ;
Penque, D ;
Gonska, T ;
Seydewitz, HH ;
Mall, M ;
Amaral, MD .
JOURNAL OF MEDICAL GENETICS, 2003, 40 (07) :e88